Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-8-3
pubmed:abstractText
We encounter hyper-3-oxo-Delta(4) bile aciduria in patients with severe cholestatic liver disease or fulminant liver failure during the neonatal period. However, simply by bile acid analysis, it is difficult to distinguish hyper-3-oxo-Delta(4) bile aciduria from primary 3-oxo-Delta(4)-steroid 5beta-reductase deficiency.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1440-1746
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
776-85
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:19175828-Autopsy, pubmed-meshheading:19175828-Bile Acids and Salts, pubmed-meshheading:19175828-Cholestasis, pubmed-meshheading:19175828-DNA Mutational Analysis, pubmed-meshheading:19175828-Diagnosis, Differential, pubmed-meshheading:19175828-Fatal Outcome, pubmed-meshheading:19175828-Female, pubmed-meshheading:19175828-Genetic Testing, pubmed-meshheading:19175828-Heterozygote, pubmed-meshheading:19175828-Humans, pubmed-meshheading:19175828-Infant, Newborn, pubmed-meshheading:19175828-Japan, pubmed-meshheading:19175828-Liver, pubmed-meshheading:19175828-Male, pubmed-meshheading:19175828-Metabolism, Inborn Errors, pubmed-meshheading:19175828-Mutation, pubmed-meshheading:19175828-Oxidoreductases, pubmed-meshheading:19175828-Phenotype, pubmed-meshheading:19175828-Predictive Value of Tests, pubmed-meshheading:19175828-Taiwan, pubmed-meshheading:19175828-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency.
pubmed:affiliation
Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
pubmed:publicationType
Journal Article, Case Reports, Multicenter Study